About BrainStorm Cell Therapeutics

Sponsor retains sole responsibility for content.

BrainStorm Cell Therapeutics (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig’s disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD).

Contact BrainStorm Cell Therapeutics

Phone Number
M: +972-50-8443422 / T: +972-3-9236384

More About BrainStorm Cell Therapeutics

Therapeutic Areas
  • Central Nervous System
Technologies
  • Regenerative medicine
Company Type
  • Biotechnology – Therapeutics
State of Ownership
  • Public
Sponsorship Group
  • Networker